Carregant...
Isavuconazole in Hematological Patients: Results of a Real-Life Multicentre Observational Seifem Study
Invasive fungal diseases (IFDs) remain a major clinical issue in patients with hematological malignancies (HMs). To confirm the efficacy and safety of the new azole isavuconazole (ISV) in a clinical care setting, we planned a multicenter retrospective study; we collected data on all possible/probabl...
Guardat en:
| Publicat a: | Hemasphere |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Wolters Kluwer Health
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6924559/ https://ncbi.nlm.nih.gov/pubmed/31976489 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000320 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|